Eli Lilly and Company Profile (NYSE:LLY)

About Eli Lilly and

Eli Lilly and logoEli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LLY
  • CUSIP: 53245710
Key Metrics:
  • Previous Close: $81.16
  • 50 Day Moving Average: $79.37
  • 200 Day Moving Average: $76.87
  • 52-Week Range: $1,057,699,000.00 - $67.88
  • Trailing P/E Ratio: 34.70
  • Foreward P/E Ratio: 19.84
  • P/E Growth: 1.73
  • Market Cap: $85.14B
  • Outstanding Shares: 1,057,699,000
  • Beta: 0.2
Profitability:
  • Net Margins: 11.97%
  • Return on Equity: 23.99%
  • Return on Assets: 9.98%
Debt:
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 1.54%
  • Quick Ratio: 1.10%
Additional Links:
Companies Related to Eli Lilly and:

Analyst Ratings

Consensus Ratings for Eli Lilly and (NYSE:LLY) (?)
Ratings Breakdown: 3 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $97.82 (20.53% upside)

Analysts' Ratings History for Eli Lilly and (NYSE:LLY)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
9/14/2016Jefferies GroupReiterated RatingBuy$105.00View Rating Details
9/8/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$92.00 -> $95.00View Rating Details
8/13/2016Leerink SwannReiterated RatingOutperform$105.00View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/2/2016ArgusBoost Price TargetBuy$90.00 -> $95.00View Rating Details
7/27/2016BMO Capital MarketsReiterated RatingBuy$94.00View Rating Details
7/6/2016Credit Suisse Group AGReiterated RatingBuy$91.00View Rating Details
6/15/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details
6/4/2016Morgan StanleyReiterated RatingHold$88.00View Rating Details
4/6/2016Societe GeneraleInitiated CoverageHold$78.00View Rating Details
2/4/2016Berenberg BankBoost Price TargetBuy$105.00 -> $106.00View Rating Details
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$88.00 -> $86.00View Rating Details
1/29/2016Sanford C. BernsteinLower Price TargetOutperform$93.00 -> $92.00View Rating Details
12/22/2015Bank of America Corp.Reiterated RatingBuy$104.00 -> $108.00View Rating Details
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$100.00View Rating Details
12/9/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$75.00 -> $95.00View Rating Details
8/21/2015Cowen and CompanyReiterated RatingOutperform$92.00View Rating Details
2/23/2015Tigress FinancialReiterated RatingBuyView Rating Details
10/2/2014GuggenheimInitiated CoverageBuy$80.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Eli Lilly and (NYSE:LLY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/26/2016Q216$0.86$0.86$5.14 billion$5.40 billionViewListenView Earnings Details
4/26/2016Q116$0.85$0.83$4.82 billion$4.87 billionViewListenView Earnings Details
1/28/2016Q415$0.78$0.78$5.33 billion$5.38 billionViewListenView Earnings Details
10/22/2015Q315$0.76$0.89$4.99 billion$4.96 billionViewListenView Earnings Details
7/23/2015Q215$0.74$0.90$4.89 billion$4.98 billionViewListenView Earnings Details
4/23/2015Q115$0.76$0.87$4.62 billion$4.64 billionViewN/AView Earnings Details
1/30/2015Q414$0.74$0.75$5.21 billion$5.12 billionViewN/AView Earnings Details
10/23/2014Q314$0.67$0.66$4.83 billion$4.88 billionViewListenView Earnings Details
7/24/2014Q214$0.65$0.68$4.88 billion$4.94 billionViewN/AView Earnings Details
4/24/2014Q114$0.70$0.70$4.78 billion$4.68 billionViewN/AView Earnings Details
1/30/2014Q413$0.72$0.74$5.46 billion$5.81 billionViewListenView Earnings Details
10/23/2013Q313$1.04$1.11$5.76 billion$5.77 billionViewN/AView Earnings Details
7/24/2013Q2 2013$1.01$1.16$5.82 billion$5.93 billionViewN/AView Earnings Details
4/24/2013Q1 2013$1.05$1.14$5.66 billion$5.60 billionViewN/AView Earnings Details
1/29/2013Q4 2012$0.82$0.85$5.78 billion$5.96 billionViewN/AView Earnings Details
10/24/2012$0.82$0.79ViewN/AView Earnings Details
7/25/2012$0.76$0.83ViewN/AView Earnings Details
4/25/2012$0.80$0.92ViewN/AView Earnings Details
1/31/2012$0.80$0.87ViewN/AView Earnings Details
10/20/2011$1.12$1.13ViewN/AView Earnings Details
7/21/2011$1.18$1.18ViewN/AView Earnings Details
4/18/2011$1.16$1.24ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Eli Lilly and (NYSE:LLY)
Current Year EPS Consensus Estimate: $3.59 EPS
Next Year EPS Consensus Estimate: $4.09 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.80$0.86$0.83
Q2 20163$0.85$0.88$0.86
Q3 20162$0.90$0.92$0.91
Q4 20162$0.94$1.05$1.00
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Eli Lilly and (NYSE:LLY)
Annual Dividend:$2.04
Dividend Yield:2.51%
Dividend Growth:0.70% (3 Year Average)
Payout Ratio:87.93% (Based on Trailing 12 Months of Earnings)
56.82% (Based on Current Year Consensus EPS Estimate)
49.88% (Based on Next Year Consensus EPS Estimate)

Dividend History for Eli Lilly and (NYSE:LLY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/20/2016quarterly$0.512.81%8/11/20168/15/20169/9/2016
5/2/2016quarterly$0.512.68%5/11/20165/13/20166/10/2016
12/8/2015quarterly$0.512.43%2/10/20162/12/20163/10/2016
10/19/2015quarterly$0.502.57%11/10/201511/13/201512/10/2015
6/15/2015quarterly$0.502.42%8/12/20158/14/20159/10/2015
5/4/2015quarterly$0.502.78%5/14/20155/18/20156/10/2015
12/15/2014quarterly$0.502.89%2/11/20152/13/20153/10/2015
10/20/2014quarterly$0.493.03%11/12/201411/14/201412/10/2014
6/16/2014quarterly$0.493.31%8/13/20148/15/20149/10/2014
5/5/2014quarterly$0.493.35%5/13/20145/15/20146/10/2014
12/16/2013quarterly$0.493.98%2/12/20142/14/20143/10/2014
10/21/2013quarterly$0.493.91%11/13/201311/15/201312/10/2013
6/18/2013quarterly$0.493.82%8/13/20138/15/20139/10/2013
5/6/2013quarterly$0.493.62%5/14/20135/16/20136/10/2013
12/17/2012quarterly$0.493.96%2/13/20132/15/20133/8/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Eli Lilly and (NYSE:LLY)
Insider Ownership Percentage: 0.20%
Institutional Ownership Percentage: 74.96%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Jackson P TaiDirectorBuy5,773$80.43$464,322.39View SEC Filing  
8/12/2016Jackson P TaiDirectorBuy2,560$80.42$205,875.20View SEC Filing  
7/29/2016Lilly Endowment IncMajor ShareholderSell205,000$82.94$17,002,700.00View SEC Filing  
7/28/2016Donald A ZakrowskiInsiderSell1,213$83.16$100,873.08View SEC Filing  
7/28/2016Lilly Endowment IncMajor ShareholderSell240,000$82.87$19,888,800.00View SEC Filing  
7/12/2016Lilly Endowment IncMajor ShareholderSell210,000$79.54$16,703,400.00View SEC Filing  
7/7/2016Lilly Endowment IncMajor ShareholderSell225,000$79.14$17,806,500.00View SEC Filing  
6/30/2016Lilly Endowment IncMajor ShareholderSell215,000$78.46$16,868,900.00View SEC Filing  
6/29/2016Lilly Endowment IncMajor ShareholderSell220,000$77.86$17,129,200.00View SEC Filing  
6/10/2016Melissa S BarnesSVPSell992$73.77$73,179.84View SEC Filing  
5/31/2016Lilly Endowment IncMajor ShareholderSell200,000$75.12$15,024,000.00View SEC Filing  
5/12/2016Jackson P TaiDirectorBuy1,080$75.75$81,810.00View SEC Filing  
5/12/2016Lilly Endowment IncMajor ShareholderSell190,000$75.86$14,413,400.00View SEC Filing  
5/2/2016Donald A ZakrowskiCAOSell1,600$75.86$121,376.00View SEC Filing  
4/29/2016Lilly Endowment IncMajor ShareholderSell180,000$75.44$13,579,200.00View SEC Filing  
4/27/2016Alfonso G ZuluetaSVPSell12,000$76.27$915,240.00View SEC Filing  
4/8/2016Lilly Endowment IncMajor ShareholderSell200,000$74.29$14,858,000.00View SEC Filing  
2/5/2016Stephen F FrySVPSell15,230$78.87$1,201,190.10View SEC Filing  
2/3/2016David A. RicksSVPSell5,733$77.66$445,224.78View SEC Filing  
2/3/2016Derica W. RiceCFOSell10,483$77.78$815,367.74View SEC Filing  
2/1/2016Jackson P TaiDirectorBuy3,170$78.62$249,225.40View SEC Filing  
1/29/2016Alfonso G ZuluetaSVPSell5,000$78.75$393,750.00View SEC Filing  
12/21/2015Lilly Endowment IncMajor ShareholderSell205,000$86.00$17,630,000.00View SEC Filing  
12/15/2015Lilly Endowment IncMajor ShareholderSell215,000$85.60$18,404,000.00View SEC Filing  
12/9/2015Enrique A ConternoVPSell25,000$83.88$2,097,000.00View SEC Filing  
12/2/2015Lilly Endowment Incmajor shareholderSell210,000$85.09$17,868,900.00View SEC Filing  
11/20/2015Lilly Endowment Incmajor shareholderSell205,000$84.54$17,330,700.00View SEC Filing  
10/29/2015Lilly Endowment Incmajor shareholderSell200,000$82.28$16,456,000.00View SEC Filing  
10/9/2015Lilly Endowment Incmajor shareholderSell215,000$85.86$18,459,900.00View SEC Filing  
10/5/2015Lilly Endowment Incmajor shareholderSell260,000$86.46$22,479,600.00View SEC Filing  
9/18/2015Lilly Endowment Incmajor shareholderSell250,000$89.04$22,260,000.00View SEC Filing  
6/10/2015Lilly Endowment IncMajor ShareholderSell210,000$82.39$17,301,900.00View SEC Filing  
6/4/2015Lilly Endowment IncMajor ShareholderSell200,000$77.90$15,580,000.00View SEC Filing  
5/29/2015Jeffrey N SimmonsSVPSell20,000$78.08$1,561,600.00View SEC Filing  
5/20/2015Lilly Endowment IncMajor ShareholderSell190,000$73.43$13,951,700.00View SEC Filing  
5/15/2015Lilly Endowment IncMajor ShareholderSell200,000$72.83$14,566,000.00View SEC Filing  
5/8/2015Lilly Endowment IncMajor ShareholderSell195,000$73.28$14,289,600.00View SEC Filing  
5/1/2015Lilly Endowment IncMajor ShareholderSell200,000$73.09$14,618,000.00View SEC Filing  
3/30/2015Lilly Endowment IncMajor ShareholderSell180,000$73.94$13,309,200.00View SEC Filing  
3/23/2015Lilly Endowment IncMajor ShareholderSell190,000$76.97$14,624,300.00View SEC Filing  
3/9/2015Stephen F FrySVPSell4,000$69.27$277,080.00View SEC Filing  
2/4/2015David A RicksSVPSell3,147$69.99$220,258.53View SEC Filing  
2/4/2015Derica W RiceCFOSell5,316$70.00$372,120.00View SEC Filing  
2/4/2015Jan M LundbergEVPSell11,085$70.08$776,836.80View SEC Filing  
2/3/2015Jan M LundbergEVPSell121,711$70.78$8,614,704.58View SEC Filing  
2/2/2015David A RicksSVPSell4,769$71.51$341,031.19View SEC Filing  
2/2/2015Derica W RiceCFOSell10,068$71.84$723,285.12View SEC Filing  
12/4/2014Lilly Endowment IncMajor ShareholderSell190,000$71.92$13,664,800.00View SEC Filing  
12/2/2014Lilly Endowment IncMajor ShareholderSell180,000$70.14$12,625,200.00View SEC Filing  
11/13/2014Lilly Endowment IncMajor ShareholderSell200,000$67.73$13,546,000.00View SEC Filing  
11/5/2014Lilly Endowment IncMajor ShareholderSell180,000$67.00$12,060,000.00View SEC Filing  
11/4/2014Fionnuala M WalshSVPSell15,000$67.00$1,005,000.00View SEC Filing  
11/3/2014Enrique A ConternoVPSell5,000$66.03$330,150.00View SEC Filing  
10/31/2014Fionnuala M WalshSVPSell7,376$66.58$491,094.08View SEC Filing  
10/31/2014Lilly Endowment IncMajor ShareholderSell190,000$66.40$12,616,000.00View SEC Filing  
10/30/2014Lilly Endowment IncMajor ShareholderSell175,000$66.58$11,651,500.00View SEC Filing  
10/24/2014Maria A CroweInsiderSell2,750$65.77$180,867.50View SEC Filing  
10/6/2014Lilly Endowment IncMajor ShareholderSell210,000$65.63$13,782,300.00View SEC Filing  
10/1/2014Enrique A ConternoVPSell5,000$64.86$324,300.00View SEC Filing  
9/30/2014Lilly Endowment IncMajor ShareholderSell200,000$65.07$13,014,000.00View SEC Filing  
9/10/2014Lilly Endowment IncMajor ShareholderSell210,000$64.77$13,601,700.00View SEC Filing  
9/3/2014Lilly Endowment IncMajor ShareholderSell200,000$63.99$12,798,000.00View SEC Filing  
9/2/2014Enrique A ConternoVPSell5,000$63.60$318,000.00View SEC Filing  
7/29/2014Lilly Endowment IncMajor ShareholderSell250,000$63.03$15,757,500.00View SEC Filing  
7/28/2014Susan MahonySVPSell2,065$63.30$130,714.50View SEC Filing  
7/25/2014Enrique A ConternoVPSell10,000$63.79$637,900.00View SEC Filing  
7/25/2014Susan MahonySVPSell30,000$63.90$1,917,000.00View SEC Filing  
7/1/2014Lilly Endowment IncMajor ShareholderSell235,000$62.30$14,640,500.00View SEC Filing  
6/25/2014Lilly Endowment IncMajor ShareholderSell245,000$62.68$15,356,600.00View SEC Filing  
6/20/2014Lilly Endowment IncMajor ShareholderSell230,000$61.55$14,156,500.00View SEC Filing  
6/16/2014Lilly Endowment IncMajor ShareholderSell200,000$58.73$11,746,000.00View SEC Filing  
6/5/2014Lilly Endowment IncMajor ShareholderSell190,000$59.53$11,310,700.00View SEC Filing  
5/21/2014Lilly Endowment Incmajor shareholderSell230,000$58.90$13,547,000.00View SEC Filing  
5/12/2014Jackson TaiDirectorBuy17,157$59.19$1,015,522.83View SEC Filing  
5/12/2014Lilly Endowment Incmajor shareholderSell210,000$59.33$12,459,300.00View SEC Filing  
5/6/2014Lilly Endowment Incmajor shareholderSell190,000$58.79$11,170,100.00View SEC Filing  
4/29/2014Lilly Endowment Incmajor shareholderSell200,000$59.43$11,886,000.00View SEC Filing  
4/28/2014Lilly Endowment Incmajor shareholderSell150,000$58.64$8,796,000.00View SEC Filing  
8/15/2013Enrique ConternoVPSell5,000$53.79$268,950.00View SEC Filing  
7/29/2013Jacques TapieroSVPSell7,500$53.74$403,050.00View SEC Filing  
7/15/2013Enrique A ConternoVPSell5,000$51.43$257,150.00View SEC Filing  
6/17/2013Enrique A ConternoVPSell5,000$52.45$262,250.00View SEC Filing  
5/15/2013Enrique A ConternoVPSell5,000$56.15$280,750.00View SEC Filing  
5/10/2013Jeffrey N SimmonsSVPSell10,000$54.49$544,900.00View SEC Filing  
3/26/2013Susan MahonySVPSell5,000$56.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Eli Lilly and (NYSE:LLY)
DateHeadline
businesswire.com logoCerecor Announces Acquisition of TARP-γ8-AMPA Receptor Antagonist (CERC-611) from Lilly (NYSE:LLY)
www.businesswire.com - September 26 at 10:34 AM
seekingalpha.com logoEli Lilly January 2017 Options: An Iron Condor Idea (NYSE:LLY)
seekingalpha.com - September 25 at 5:18 PM
News IconLechleiters Land Prestigious Award (NYSE:LLY)
www.insideindianabusiness.com - September 25 at 5:18 PM
4-traders.com logoEli Lilly and : William Conner House (NYSE:LLY)
www.4-traders.com - September 24 at 5:28 PM
News IconThe Interview Issue: Dave Ricks - Indianapolis Business Journal (NYSE:LLY)
www.ibj.com - September 24 at 10:23 AM
bloomberg.com logoHere's $160000 Toward Your Stanford MBA. And Here's the Catch - Bloomberg (NYSE:LLY)
www.bloomberg.com - September 23 at 5:37 PM
News IconAnalysts Valuations For Two Stocks: Eli Lilly and Co (NYSE:LLY ... - The Voice Registrar (NYSE:LLY)
voiceregistrar.com - September 23 at 5:37 PM
News IconDrug Manufacturers – Major: Eli Lilly and Company (NYSE:LLY) Position of the day (NYSE:LLY)
twincountynews.com - September 23 at 10:40 AM
thestreet.com logoTakeover Chatter Around Clovis May Be Overdone (NYSE:LLY)
www.thestreet.com - September 23 at 10:40 AM
News IconEli Lilly and Company (NYSE:LLY) from Drug Manufacturers – Major – Todays Top Gains (NYSE:LLY)
twincountynews.com - September 22 at 5:43 PM
News IconNew IHS Exhibit Explores the Life and Legacy of Colonel Eli Lilly (NYSE:LLY)
www.pressreleasepoint.com - September 21 at 4:11 PM
News IconLeading stocks in today’s market: Eli Lilly and Company (NYSE:LLY) (NYSE:LLY)
twincountynews.com - September 21 at 4:11 PM
thestreet.com logoEli Lilly Can't Put the Petal to the Metal (NYSE:LLY)
realmoney.thestreet.com - September 21 at 4:11 PM
News IconAnalysts Advise About Eli Lilly and Co (NYSE:LLY) - The Independent Republic (NYSE:LLY)
theindependentrepublic.com - September 21 at 10:04 AM
marketrealist.com logoTeva, Eli Lilly Have Migraine Treatments in Trial Phases (NYSE:LLY)
marketrealist.com - September 21 at 10:04 AM
finance.yahoo.com logoSanofi Sues Merck Over Patent Infringement (NYSE:LLY)
finance.yahoo.com - September 21 at 10:04 AM
News IconHC Stocks Alerts! Eli Lilly and Co (LLY), UnitedHealth Group Inc (NYSE:UNH) - share market updates (press release) (NYSE:LLY)
sharemarketupdates.com - September 20 at 11:05 AM
marketrealist.com logoAlder BioPharmaceuticals’s Migraine Therapy Shows Promise (NYSE:LLY)
marketrealist.com - September 20 at 11:05 AM
News IconHigh Market Cap Stock of the Day – Eli Lilly and Company (NYSE:LLY) (NYSE:LLY)
twincountynews.com - September 19 at 5:56 PM
News IconShares of Eli Lilly and Co (NYSE:LLY) & Corning Incorporated (NYSE:GLW) Stocks News Update: Friday (NYSE:LLY)
www.newsismoney.com - September 19 at 5:56 PM
News IconShares of Eli Lilly and Co (NYSE:LLY) & Corning Incorporated ... - Money News (NYSE:LLY)
www.newsismoney.com - September 19 at 10:29 AM
News IconA 93-year-old drug that can cost more than a mortgage payment tells us everything that's wrong with American healthcare (NYSE:LLY)
www.businessinsider.com - September 17 at 5:38 PM
finance.yahoo.com logoThere's something odd about the way insulin prices change (NYSE:LLY)
finance.yahoo.com - September 17 at 5:38 PM
prnewswire.com logoBoston Mayor Walsh and the Alzheimer's Association, Massachusetts/New Hampshire Chapter, Receive Alzheimer's ... - PR Newswire (press release) (NYSE:LLY)
www.prnewswire.com - September 17 at 10:27 AM
streetinsider.com logoEli Lilly & Co. (LLY) Receives Positive CHMP Opinion on Olaratumab Combo in Adv. STS - StreetInsider.com (NYSE:LLY)
www.streetinsider.com - September 17 at 10:27 AM
thestreet.com logoWill Eli Lilly (LLY) Stock Be Helped by European Drug Recommendation? (NYSE:LLY)
www.thestreet.com - September 16 at 5:45 PM
nasdaq.com logoEli Lilly: CHMP Issues Positive Opinion On Conditional Approval For Olaratumab (NYSE:LLY)
www.nasdaq.com - September 16 at 11:20 AM
streetinsider.com logoEli Lilly & Co. (LLY) Receives Positive CHMP Opinion on Olaratumab Combo in Adv. STS (NYSE:LLY)
www.streetinsider.com - September 16 at 11:20 AM
4-traders.com logoEli Lilly and : Assigned Patent (NYSE:LLY)
www.4-traders.com - September 16 at 11:20 AM
News IconIs Eli Lilly and Company (NYSE:LLY), a large market cap stock a smart buy? (NYSE:LLY)
twincountynews.com - September 16 at 11:20 AM
finance.yahoo.com logo7:24 am Eli Lilly: CHMP issues positive opinion recommending the granting of a conditional marketing authorization for olaratumab, in combination with doxorubicin, for the treatment of adults in the EU with advanced soft tissue sarcoma (NYSE:LLY)
finance.yahoo.com - September 16 at 11:20 AM
marketrealist.com logoAnalyst Price Targets and Recommendations for Sanofi (NYSE:LLY)
marketrealist.com - September 16 at 11:20 AM
publicnow.com logoCHMP Recommends Approval of Lilly's Olaratumab, in Combination with Doxorubicin, for Advanced Soft Tissue Sarcoma (NYSE:LLY)
www.publicnow.com - September 16 at 11:20 AM
finance.yahoo.com logoA 93-year-old drug that some children can't live without tells us everything that's wrong with American healthcare (NYSE:LLY)
finance.yahoo.com - September 15 at 3:55 PM
finance.yahoo.com logoBoston Mayor Walsh and the Alzheimer's Association, Massachusetts/New Hampshire Chapter, Receive Alzheimer's Readiness Award (NYSE:LLY)
finance.yahoo.com - September 15 at 3:55 PM
News IconEli Lilly and Co. (NYSE: LLY) Buy Rating Reiterated at Jefferies Group - BNB Daily (blog) (NYSE:LLY)
www.baseball-news-blog.com - September 15 at 9:18 AM
bloomberg.com logoNovo to Fight Back With New Products to Regain Ground in China - Bloomberg (NYSE:LLY)
www.bloomberg.com - September 14 at 6:01 PM
prnewswire.com logoLevi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor ... - PR Newswire (press release) (NYSE:LLY)
www.prnewswire.com - September 14 at 6:01 PM
marketrealist.com logoHow Sanofi’s Franchises Could Perform into 2017 (NYSE:LLY)
marketrealist.com - September 14 at 6:01 PM
News IconAnalysts Valuations For Two Stocks: SBA Communications Corporation (NASDAQ:SBAC), Eli Lilly and Co (NYSE:LLY) - The Voice Registrar (NYSE:LLY)
voiceregistrar.com - September 14 at 10:10 AM
prnewswire.com logo2020 Animal Health Market Forecasts: Sanofi, Merck and Co., Eli Lilly and Company & Zoetis Inc. Reviewed - PR Newswire (press release) (NYSE:LLY)
www.prnewswire.com - September 14 at 10:10 AM
finance.yahoo.com logoElanco's Antibiotic Stewardship Plan Yields Innovation, Scientific Advancements (NYSE:LLY)
finance.yahoo.com - September 14 at 10:10 AM
finance.yahoo.com logoLevi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career (NYSE:LLY)
finance.yahoo.com - September 14 at 10:10 AM
News IconNoteworthy Price Swings: Eli Lilly and Company's (LLY) (NYSE:LLY)
myhealthbowl.com - September 13 at 10:45 AM
247wallst.com logoJefferies Issues Top Pharma and Biohealth Stocks to Buy (NYSE:LLY)
247wallst.com - September 13 at 10:45 AM
News IconSio Capital Management adds Eli Lilly and Co (LLY) to its portfolio (NYSE:LLY)
10thousandcouples.com - September 12 at 5:42 PM
fool.com logoHow the Tides Are Turning in Alzheimer's Research (NYSE:LLY)
www.fool.com - September 12 at 5:42 PM
News IconUpdate on Eli Lilly and Company (NYSE:LLY) for the day (NYSE:LLY)
twincountynews.com - September 10 at 10:17 AM
News IconActive Healthcare Stocks in Analysts' Views- Eli Lilly and Company (NYSE:LLY), Wright Medical Group (NASDAQ:WMGI) - Seneca Globe (NYSE:LLY)
www.senecaglobe.com - September 9 at 5:43 PM
marketexclusive.com logoInside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA ... - Market Exclusive (NYSE:LLY)
marketexclusive.com - September 9 at 10:40 AM

Social

Eli Lilly and (NYSE:LLY) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff